Australia, Jan. 22 -- Bayer AG, owns the trademark (2587722) for 'HYRNUCO' till Aug. 8, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations, for use in the following fields: treatment of oncological indications; pharmaceutical preparations, for use in the following fields: treatment and prevention of cardiovascular diseases; pharmaceutical preparations for use in the following fields: treatment and prevention of inflammatory indications; pharmaceutical preparations for use in the following fields: treatment of Parkinson's disease.]
Type of Mark: Word
Date of Acceptance: Sept. 22, 2025
Registration Advertised: Jan. 21
For further details contact Christian Schalk.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2587722.
Disclaimer: Curated by HT Syndication.
